Full Description
Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
Contents
Preface
Laura N. Vandenberg and Judith L. Turgeon
1. Endocrine disruptor global policy
Christopher D. Kassotis and Leonardo Trasande
2. Toxicity testing and endocrine disrupting chemicals
Laura N. Vandenberg
3. Epigenetics, estrogenic endocrine-disrupting chemicals (EDCs), and the brain
Madeline Streifer and Andrea C. Gore
4. Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid
Heather B. Patisaul
5. Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models
Mary Jo Laws, Alison M. Neff, Emily Brehm, Genoa R. Warner and Jodi A. Flaws
6. Endocrine disrupting chemicals (EDCs) and sex steroid receptors
Julianne M. Hall and Kenneth S. Korach
7. Endocrine disrupting chemicals and the mammary gland
Laura N. Vandenberg
8. Impact of gestational exposure to endocrine disrupting chemicals on pregnancy and birth outcomes
Vasantha Padmanabhan, Jacob Moeller and Muraly Puttabyatappa
9. Endocrine disrupting chemicals (EDCs) and placental function: Impact on fetal brain development
William P. Marinello and Heather B. Patisaul
10. Endocrine disrupting chemicals and thyroid hormone action
R. Thomas Zoeller
11. Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic
Margaret C. Schulz and Robert M. Sargis
12. The new kids on the block: Emerging obesogens
Raquel Chamorro-Garcia and Almudena Veiga-Lopez
13. Endocrine disrupting chemicals and breast cancer cells
Philippa D. Darbre
14. EDCs and male urogenital cancers
M.S. Bornman and N.H. Aneck-Hahn
